Solstice Health Unveils AI Platform to Accelerate the Content Supply Chain for Biopharma Marketing Teams

Company raises $3.5 million to accelerate innovation in biopharma marketing

NEW YORK, Feb. 5, 2025 /PRNewswire/ -- Solstice Health, a life sciences marketing engine designed to bridge the gap between innovative marketing and regulatory compliance, today announced the launch of its groundbreaking platform to streamline the way biopharma marketing companies manage the content supply chain, particularly the medical-legal-regulatory (MLR) review process.

Solstice uses advanced generative AI to streamline regulatory compliance and accelerate content distribution. Despite the biopharma industry's $40 billion annual spend on advertising, many therapeutic launches are struck relying on outdated and generic strategies. Solstice is purpose-built to solve the common pain point of the time-consuming and expensive MLR process.

"Solstice is transforming the medical-legal-regulatory review process with its AI engine." said Elaine Kang, Director of Marketing at SpringWorks Therapeutics. "By flagging risks early, and ensuring first-pass approval readiness, Solstice enables marketers and review teams to focus on high-impact, strategic decisions rather than manual checks. I'm proud to be part of this journey with the team as they redefine how compliance and speed to market can go hand in hand."

Solstice has developed the industry's first AI-powered MLR assistant. The platform leverages secure, responsive AI models to assist in the regulatory review process, enabling marketing and compliance teams to get their products to market faster while ensuring full compliance with regulatory rules.

Solstice's platform is designed to integrate seamlessly into existing content creation workflows, allowing teams to evaluate content compliance within minutes instead of days or weeks, reducing evaluation cycle timelines by 74%.

“We’re excited to be working with several of the top 20 pharmaceutical brands and numerous MM&M Top 100 Agencies,” remarks Solstice co-founders Yiwen Li and Aris Saxena. “The platform elevates the work of all life sciences marketers, allowing them to push out more compliant, targeted messaging to patients and healthcare providers. We hope to eventually provide a full-stack solution to teams to help them rapidly iterate on content for launch and mature brands alike.”

Solstice has raised $3.5 million in seed funding from investors including Twelve Below and Virtue.

About Solstice
Solstice is a life sciences marketing engine designed to accelerate content review cycles for biopharma companies. For more information, visit https://www.solsticehealth.co/.

Media Contact
[email protected]

SOURCE Solstice Health